- Home
- IMRN vs GXAI Comparison
IMRN vs GXAI Comparison
Compare IMRN & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- GXAI
- Stock Information
- Founded
- IMRN 1994
- GXAI 2021
- Country
- IMRN Australia
- GXAI United States
- Employees
- IMRN N/A
- GXAI N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- GXAI
- Sector
- IMRN Health Care
- GXAI
- Exchange
- IMRN Nasdaq
- GXAI Nasdaq
- Market Cap
- IMRN 9.2M
- GXAI 9.7M
- IPO Year
- IMRN N/A
- GXAI 2023
- Fundamental
- Price
- IMRN $1.72
- GXAI $1.26
- Analyst Decision
- IMRN Strong Buy
- GXAI
- Analyst Count
- IMRN 1
- GXAI 0
- Target Price
- IMRN $5.00
- GXAI N/A
- AVG Volume (30 Days)
- IMRN 656.2K
- GXAI 152.1K
- Earning Date
- IMRN 09-08-2025
- GXAI 08-12-2025
- Dividend Yield
- IMRN N/A
- GXAI N/A
- EPS Growth
- IMRN N/A
- GXAI N/A
- EPS
- IMRN N/A
- GXAI N/A
- Revenue
- IMRN $4,048,286.00
- GXAI $27,740.00
- Revenue This Year
- IMRN N/A
- GXAI N/A
- Revenue Next Year
- IMRN N/A
- GXAI N/A
- P/E Ratio
- IMRN N/A
- GXAI N/A
- Revenue Growth
- IMRN 82.90
- GXAI 9987.27
- 52 Week Low
- IMRN $1.50
- GXAI $1.00
- 52 Week High
- IMRN $2.87
- GXAI $7.50
- Technical
- Relative Strength Index (RSI)
- IMRN 45.31
- GXAI 45.07
- Support Level
- IMRN $1.60
- GXAI $1.22
- Resistance Level
- IMRN $1.80
- GXAI $1.31
- Average True Range (ATR)
- IMRN 0.10
- GXAI 0.07
- MACD
- IMRN -0.01
- GXAI -0.00
- Stochastic Oscillator
- IMRN 34.09
- GXAI 26.00
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
About GXAI Gaxos.ai Inc.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.